Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

351
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
351

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized air quality monitoring and respiratory health in moderate and severe asthma: Findings from a six-month observational study.

Environment international·2026
Same author

Organizing pneumonia in hospitalized COVID-19 patients: risk factors and long-term outcomes.

Pneumonia (Nathan Qld.)·2025
Same author

Empyema Necessitatis caused by Actinomycesmeyeri.

Archivos de bronconeumologia·2025
Same author

Resources and Readmission for COPD Exacerbation in Pneumology Units in Spain: The COPD Observatory Project.

Healthcare (Basel, Switzerland)·2025
Same author

[Highlights 57th SEPAR Congress].

Open respiratory archives·2024
Same author

Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

Frontiers in medicine·2023
Same journal

When Pneumonia is not Pneumonia: Pulmonary Venous Thrombosis After Scimitar Syndrome Repair.

Open respiratory archives·2026
Same journal

Building the Future of Interventional Pulmonology: Reflections from the Forum of La Gomera.

Open respiratory archives·2026
Same journal

[Sepsis in the Intermediate Respiratory Care Unit: Restrospective Study].

Open respiratory archives·2026
Same journal

Pulmonary Mass as a Rare Pulmonary Manifestation of Inflammatory Bowel Disease.

Open respiratory archives·2026
Same journal

[BioSAT: Development and conceptual validation of a satisfaction questionnaire regarding biologic therapies for severe asthma through a structured patient-professional co-creation process].

Open respiratory archives·2026
Same journal

Nintedanib in a Dialysis Patient with Idiopathic Pulmonary Fibrosis: A One-Year Follow-Up Without Major Adverse Events.

Open respiratory archives·2026
See all related articles

Related Experiment Video

Updated: Jul 21, 2025

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

739

[Chronic Obstructive Pulmonary Disease].

Elena García Castillo1, Gianna Vargas2, José Alfonso García Guerra3

  • 1Servicio de Neumología, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria La Princesa, Universidad Autónoma de Madrid (UAM), Madrid, España. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España.

Open Respiratory Archives
|July 27, 2023
PubMed
Summary
This summary is machine-generated.

Chronic Obstructive Pulmonary Disease (COPD) management involves personalized treatments based on phenotypes and treatable traits. Early screening and understanding exacerbation biomarkers are crucial for improving patient outcomes and quality of life.

Keywords:
COPDDiagnosisEtiologyTreatment

More Related Videos

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

822
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.3K

Related Experiment Videos

Last Updated: Jul 21, 2025

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

739
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

822
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.3K

Area of Science:

  • Respiratory Medicine
  • Pulmonology
  • Clinical Science

Context:

  • Chronic Obstructive Pulmonary Disease (COPD) is a major health concern, primarily linked to smoking but influenced by multiple risk factors.
  • Accurate diagnosis relies on persistent respiratory symptoms, risk exposure, and irreversible obstructive spirometry, yet underdiagnosis remains significant.
  • Current diagnostic methods necessitate spirometry, prompting research into alternative screening approaches.

Purpose:

  • To explore advancements in personalized medicine for COPD through clinical phenotypes and treatable traits.
  • To highlight the importance of non-pharmacological and phenotype-based pharmacological treatments.
  • To emphasize the role of eosinophils as a biomarker for inhaled glucocorticoid therapy.

Summary:

  • COPD diagnosis requires spirometry, but alternative screening methods are under development due to significant underdiagnosis.
  • Personalized medicine utilizes clinical phenotypes and treatable traits to tailor treatments, including non-pharmacological interventions and targeted pharmacotherapy.
  • Eosinophil counts are key for guiding inhaled glucocorticoid use, and monitoring exacerbation control is vital for patient prognosis.

Impact:

  • Advances in COPD management through personalized treatment strategies.
  • Improved patient care via tailored therapies and biomarker-guided interventions.
  • Enhanced understanding of COPD exacerbations, paving the way for future research and improved clinical guidelines.